28
Participants
Start Date
May 12, 2010
Primary Completion Date
September 16, 2011
Study Completion Date
November 29, 2012
subcutanious administration
drug will be administered subcutaneously in varying amounts over a verying time period according to details stated in the 'arms' section
Placebo
Placebo will be given to one member of each cohort.
GSK Investigational Site, Moscow
Lead Sponsor
GlaxoSmithKline
INDUSTRY